Steven Cohen’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126M Buy
3,535,080
+3,399,433
+2,506% +$108M 0.14% 160
2026
Q2
$3.73M Buy
+135,647
New +$3.61M ﹤0.01% 1977
2025
Q3
– Sell
-538,500
Closed -$11.1M – 2458
2025
Q2
$11.1M Sell
538,500
-385,367
-42% -$7.91M 0.02% 693
2025
Q1
$18.1M Buy
923,867
+835,721
+948% +$17.5M 0.04% 477
2024
Q4
$1.84M Buy
+88,146
New +$1.94M ﹤0.01% 1277
2024
Q3
– Sell
-18,184
Closed -$457K – 2123
2024
Q2
$457K Buy
+18,184
New +$516K ﹤0.01% 1463
2024
Q1
– Sell
-101,100
Closed -$3.22M – 2335
2023
Q4
$3.22M Sell
101,100
-177,501
-64% -$5.57M 0.01% 1065
2023
Q3
$9.8M Buy
278,601
+101,101
+57% +$3.85M 0.03% 665
2023
Q2
$6.75M Sell
177,500
-83,266
-32% -$3.32M 0.02% 713
2023
Q1
$9.8M Buy
+260,766
New +$10M 0.03% 551
2021
Q4
– Sell
-56,600
Closed -$2.47M – 1170
2021
Q3
$2.47M Sell
56,600
-385,000
-87% -$17.3M 0.01% 769
2021
Q2
$18M Buy
441,600
+212,900
+93% +$8.22M 0.08% 305
2021
Q1
$7.51M Buy
+228,700
New +$8.6M 0.04% 492

Other funds holding GMAB

Steven Cohen's GMAB Position: Q3 2026 in Review

Steven Cohen increased its Genmab (GMAB) stake by 2,506% in Q3 2026, buying an estimated $108M and bringing the position to 3,535,080 shares worth $126M. The position accounts for 0.14% of the portfolio, ranked #160.

Steven Cohen first reported a position in GMAB in Q1 2021 and has held it in 13 quarters since. 333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • Steven Cohen held 3,535,080 shares of Genmab worth $126M as of Q3 2026.
  • Steven Cohen bought 3,399,433 Genmab shares in Q3 2026, an estimated $108M.
  • Genmab made up 0.14% of Steven Cohen's portfolio in Q3 2026, its #160 holding.
  • Steven Cohen first reported a position in Genmab in Q1 2021 and has held it in 13 quarters since.
  • 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.